39647-97-7

Basic information

• Product Name: Pentanoic acid, 5-(triphenylphosphoranylidene)-, potassium salt
• CAS NO: 39647-97-7
• Molecular Formula: C23H23O2P.K
• Molecular Weight: 400.499
• Mol File: 39647-97-7.mol

Chemical Properties

• CAS DataBase Reference: Pentanoic acid, 5-(triphenylphosphoranylidene)-, potassium salt(CAS DataBase Reference)
• NIST Chemistry Reference: Pentanoic acid, 5-(triphenylphosphoranylidene)-, potassium salt(39647-97-7)
• EPA Substance Registry System: Pentanoic acid, 5-(triphenylphosphoranylidene)-, potassium salt(39647-97-7)

Safety Data

• Hazardous Substances Data: 39647-97-7(Hazardous Substances Data)

Upstream product

• 17814-85-6 (4-carboxybutyl)triphenylphosphonium bromide 

Downstream Products

• 1240483-17-3 (Z)-7-((1R,2R,3R,5S)-3-((tert-butyldimethylsilyl)oxy)-2-((S,E)-3-((tert-butyldimethylsilyl)oxy)-5-phenylpent-1-en-1-yl)-5-hydroxycyclopentyl)hept-5-enoic acid 
• 1289580-02-4 (Z)-7-((1R,2R,3R,5S)-5-(tert-butyldimethylsilyloxy)-2-((S,E)-3-(tert-butyldimethylsilyloxy)-5-phenylpent-1-enyl)-3-hydroxycyclopentyl)hept-5-enoic acid 
• 128888-87-9 (Z)-7-((1R,2S)-5-Oxo-2-phenyl-cyclohexyl)-hept-5-enoic acid 
• 128888-86-8 (Z)-7-((1R,2S,5R)-5-Hydroxy-2-phenyl-cyclohexyl)-hept-5-enoic acid 

Relevant articles and documents

Thromboxane receptor antagonism combined with thromboxane synthase inhibition. 1. (±)-(3-Pyridinylbicycloheptyl)alkanoic acids

The design, synthesis, and in vitro pharmacology of a new class of compounds exerting both thromboxane receptor antagonist and thromboxane synthase inhibtory activities is described. [(3-Pyridinyl)bicycloheptyl]alkanoic acid 9 and its analogues, designed

PROCESS FOR THE PREPARATION OF F-SERIES PROSTAGLANDINS

A process for the synthesis and purification of F-series prostaglandin compounds and synthetic intermediates used to prepare them. The synthetic intermediates are solid and may be purified by precipitation and therefore may form the representative F-series prostaglandin compounds such as latanoprost, bimatoprost, fluprostenol, cloprostenol, and substituted analogs therefrom in highly pure forms.